These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2042 related items for PubMed ID: 31818312

  • 1. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W, Xiao G, Xie G, Chen Z, Xu X, Zeng J, Xie J.
    Thorac Cancer; 2024 Sep 09; 15(26):1871-1881. PubMed ID: 39090761
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.
    Yang T, Li H, Chen T, Ren H, Shi P, Chen M.
    Mol Cells; 2019 Mar 31; 42(3):270-283. PubMed ID: 30841025
    [Abstract] [Full Text] [Related]

  • 8. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H, Yao J, Wang Y, Ni B.
    Drug Deliv; 2022 Dec 31; 29(1):1257-1271. PubMed ID: 35467477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2021 Feb 23; 14(1):32. PubMed ID: 33618740
    [No Abstract] [Full Text] [Related]

  • 11. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug 23; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.
    Cao Y, Di X, Cong S, Tian C, Wang Y, Jin X, Zhao M, Zhou X, Li R, Wang K.
    Life Sci; 2023 Feb 15; 315():121359. PubMed ID: 36608868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
    Song Z, Jia G, Ma P, Cang S.
    Life Sci; 2021 Jul 01; 276():119399. PubMed ID: 33781830
    [Abstract] [Full Text] [Related]

  • 18. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, Chen S, Lu Q, Yang DH.
    Cancer Lett; 2024 Aug 10; 597():217058. PubMed ID: 38880226
    [Abstract] [Full Text] [Related]

  • 19. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner.
    Zhang R, Chen P, Wang Y, Zeng Z, Yang H, Li M, Liu X, Yu W, Hou P.
    Int J Biol Sci; 2024 Aug 10; 20(12):4750-4766. PubMed ID: 39309428
    [Abstract] [Full Text] [Related]

  • 20. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
    Wang D, Zhang S, Zhao M, Chen F.
    Cancer Med; 2020 Dec 10; 9(23):9138-9149. PubMed ID: 33146951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.